Top Markets
Coin of the day
Chordate Medical Holding AB (publ) Chordate Medical Holding AB (publ)

Chordate Medical Holding AB (publ)

CMH
Rank in Stocks #41272
Established in 2005 and based in Kista, Sweden, Chordate Medical Holding AB... Established in 2005 and based in Kista, Sweden, Chordate Medical Holding AB (publ) is a medical technology company. This firm concentrates on developing products and solutions for the treatment of chronic migraine and rhinitis. Its specialization lies within the ear-nose and throat (ENT) area, with its operations primarily conducted in Sweden.
Share Price
$0.01116935
Last synced: 2026-03-04
Market Cap
$30.15K
Change (1 day)
-37.50%
Change (1 year)
-98.35%
Country
SE
Trade Chordate Medical Holding AB (publ) (CMH)

Category

P/E ratio for Chordate Medical Holding AB (publ) (CMH)
P/E ratio as of 2026 TTM: 0
According to Chordate Medical Holding AB (publ) latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Chordate Medical Holding AB (publ) from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
33.99 -
US
33.47 -
US
21.39 -
IE
18.84 -
US
49.47 -
US
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.